If you liked this article you might like

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Merrimack Pharmaceuticals (MACK) Weak On High Volume Today
Merrimack Pharmaceuticals (MACK) Is Weak On High Volume Today